NasdaqGS - Nasdaq Real Time Price • USD
Bolt Biotherapeutics, Inc. (BOLT)
At close: April 18 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -0.51 | -0.48 | -1.65 | -1.09 |
| Low Estimate | -0.57 | -0.59 | -1.96 | -1.72 |
| High Estimate | -0.47 | -0.28 | -1.22 | -0.25 |
| Year Ago EPS | -0.45 | -0.48 | -1.83 | -1.65 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 4 |
| Avg. Estimate | 2.06M | 1.93M | 7.16M | 4.56M |
| Low Estimate | 1.5M | 1.2M | -- | -- |
| High Estimate | 2.8M | 3.1M | 12.52M | 11.11M |
| Year Ago Sales | 1.83M | 1.43M | 7.88M | 7.16M |
| Sales Growth (year/est) | 12.80% | 34.70% | -9.10% | -36.30% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.51 | -0.49 | -0.5 | -0.48 |
| EPS Actual | -0.45 | -0.48 | -0.43 | -0.47 |
| Difference | 0.06 | 0.01 | 0.07 | 0.01 |
| Surprise % | 11.80% | 2.00% | 14.00% | 2.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.51 | -0.48 | -1.65 | -1.09 |
| 7 Days Ago | -0.51 | -0.48 | -1.65 | -1.09 |
| 30 Days Ago | -0.52 | -0.28 | -1.64 | -1.33 |
| 60 Days Ago | -0.52 | -0.28 | -1.64 | -1.33 |
| 90 Days Ago | -0.52 | -0.28 | -1.63 | -1.31 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 2 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | BOLT | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -13.30% | -- | -- | 0.80% |
| Next Qtr. | 0.00% | -- | -- | 9.60% |
| Current Year | 9.80% | -- | -- | 4.50% |
| Next Year | 33.90% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/22/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/8/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 8/3/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/5/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 5/26/2023 |
| Upgrade | SVB Leerink: Market Perform to Outperform | 5/12/2023 |
Related Tickers
ACHL Achilles Therapeutics plc
0.8000
-2.91%
NXTC NextCure, Inc.
1.5700
+3.97%
BCAB BioAtla, Inc.
2.4300
-3.95%
SNSE Sensei Biotherapeutics, Inc.
0.9829
-1.71%
CTMX CytomX Therapeutics, Inc.
1.7300
-1.70%
CMPX Compass Therapeutics, Inc.
1.4900
-2.61%
ALGS Aligos Therapeutics, Inc.
0.7931
+0.78%
LVTX LAVA Therapeutics N.V.
2.8300
-3.74%
DSGN Design Therapeutics, Inc.
3.7400
-5.08%
GBIO Generation Bio Co.
2.7800
-6.71%